Glenmark Life Sciences Ltd. is proposing an Initial Public Offering (IPO) on the NSE & BSE platform under the Mainboard category.
Subscription opens 27 Jul 2021, closes 29 Jul 2021. Listing expected 06 Aug 2021. Apply via ASBA or UPI.
Glenmark Life Sciences Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹14,400 |
| Retail (Max) | 13 | 260 | ₹187,200 |
| sNII (Min) | 14 | 280 | ₹201,600 |
| bNII (Min) | 70 | 1,400 | ₹1,008,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |